ICU Medical
ICUI
276 hedge funds and large institutions have $4.66B invested in ICU Medical in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 94 increasing their positions, 92 reducing their positions, and 24 closing their positions.
39% more call options, than puts
Call options by funds: $53.7M | Put options by funds: $38.6M
17% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 24
12% more capital invested
Capital invested by funds: $4.17B → $4.66B (+$489M)
2% more repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 92
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less funds holding
Funds holding: 277 → 276 (-1)
1.56% less ownership
Funds ownership: 95.68% → 94.13% (-1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$66.9M |
| 2 |
Barclays
London,
United Kingdom
|
+$23.5M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$18.6M |
| 4 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$18.2M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
+$10.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FPP
Findlay Park Partners
London,
United Kingdom
|
-$135M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$58.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$29.2M |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$24M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$12M |
ICUI Hedge Fund Activity: Q3 2021 in Review
276 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q3 2021, worth a combined $4.66B — up 12% from $4.17B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new ICUI positions and 24 closed out — a net gain of 4 holders — while 94 added to existing stakes and 92 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $66.9M. The largest seller was Findlay Park Partners, exiting entirely with an estimated $135M sold.
- 276 institutional investors held ICU Medical (ICUI) as of Q3 2021, down from 277 in Q2 2021.
- Funds reported $4.66B of ICU Medical stock for Q3 2021, up 12% quarter-over-quarter.
- 28 funds opened new ICU Medical positions in Q3 2021 and 24 closed out, a net change of +4 holders.
- The largest ICU Medical buyer in Q3 2021 was T. Rowe Price Associates, an estimated $66.9M added.
- The largest ICU Medical seller in Q3 2021 was Findlay Park Partners, an estimated $135M sold.
Based on aggregated 13F filings for Q3 2021.